Bill

HR 1922

Ensuring Access to Essential Drugs Act

119th Congress Introduced by Andrew Garbarino and 2 co-sponsors

The Ensuring Access to Essential Drugs Act aims to improve access and affordability of vital medications, benefiting patients and healthcare providers while regulating drug prices.

Introduced in House

WeVote Research Nonpartisan

Bill Summary · HR 1922

Summary of HR 1922 - Ensuring Access to Essential Drugs Act

Bill Overview

Bill Number: HR 1922
Title: Ensuring Access to Essential Drugs Act
Status: Introduced in House
Introduced Date: March 06, 2025
Classification: Bill

Purpose and Intent

The Ensuring Access to Essential Drugs Act aims to enhance the availability and affordability of essential medications for patients across the United States. The bill seeks to address the growing concerns regarding drug shortages and high prescription costs, ensuring that critical medications remain accessible to those who need them most.

Key Provisions

While the full text of the bill is not provided, the following key provisions are anticipated based on the bill's title and legislative intent:

Increased Transparency: The bill may require pharmaceutical companies to report on drug production levels and shortages to better inform healthcare providers and patients.
Price Regulation: It could include measures to regulate the pricing of essential drugs, ensuring that they remain affordable for consumers, particularly those with low income or without insurance.
Support for Generic Drugs: The legislation may promote the development and approval of generic alternatives to essential medications, fostering competition and lowering prices.
Emergency Response Framework: The bill may establish protocols for addressing drug shortages during public health emergencies, ensuring that critical medications are prioritized for distribution.

Affected Parties

The Ensuring Access to Essential Drugs Act would primarily impact:

Patients: Individuals requiring essential medications would benefit from improved access and potentially lower costs.
Healthcare Providers: Doctors and pharmacists would receive better information regarding drug availability, aiding in treatment decisions.
Pharmaceutical Companies: The bill may impose new reporting requirements and pricing regulations, affecting how companies operate within the market.

Legislative Process

Introduced: The bill was introduced in the House on March 06, 2025.
Committee Referral: It has been referred to the Committee on Energy and Commerce and the Committee on Ways and Means for further consideration. The Speaker will determine the timeline for these committees to review the bill.

Conclusion

The Ensuring Access to Essential Drugs Act represents a significant effort to tackle the challenges of drug accessibility and affordability in the U.S. healthcare system. As the bill progresses through the legislative process, further details will emerge regarding its specific provisions and potential impacts on the healthcare landscape.

Compiled from official sources — confirm details with the bill’s official record.